Where does CARM stock trade?

Carisma Therapeutics Inc. (CARM) is listed on NASDAQ.

What sector and industry is CARM in?

Carisma Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.

When did Carisma Therapeutics Inc. go public?

Carisma Therapeutics Inc. (CARM) completed its IPO in 2014.

What are analysts saying about CARM?

Carisma Therapeutics Inc. has had 8 recent analyst actions on file. The most recent action was from Robert W. Baird: Neutral with a $100.00 price target on 2024-12-12.

What companies are similar to CARM?

Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare CARM side-by-side with any of them on Quantisnow.

How can I track CARM on Quantisnow?

Quantisnow aggregates Carisma Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CARM to receive live email and push alerts on every new disclosure.

CARM

NASDAQ

Carisma Therapeutics Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2014

News25/Ratings8

News · 26 weeks230%

2025-12-142026-06-07

Mix090d

No activity.

Latest news

25 items

161dSEC
SEC Form 15-12G filed by Carisma Therapeutics Inc.
15-12G - Carisma Therapeutics Inc. (0001485003) (Filer)
173dSEC
SEC Form EFFECT filed by Carisma Therapeutics Inc.
EFFECT - Carisma Therapeutics Inc. (0001485003) (Filer)
173dSEC
SEC Form EFFECT filed by Carisma Therapeutics Inc.
EFFECT - Carisma Therapeutics Inc. (0001485003) (Filer)
173dSEC
SEC Form EFFECT filed by Carisma Therapeutics Inc.
EFFECT - Carisma Therapeutics Inc. (0001485003) (Filer)
173dSEC
SEC Form EFFECT filed by Carisma Therapeutics Inc.
EFFECT - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form POS AM filed by Carisma Therapeutics Inc.
POS AM - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form POS AM filed by Carisma Therapeutics Inc.
POS AM - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form POS AM filed by Carisma Therapeutics Inc.
POS AM - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form POS AM filed by Carisma Therapeutics Inc.
POS AM - Carisma Therapeutics Inc. (0001485003) (Filer)
175dSEC
SEC Form 25 filed by Carisma Therapeutics Inc.
25 - Carisma Therapeutics Inc. (0001485003) (Filer)
185dSEC
Carisma Therapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Carisma Therapeutics Inc. (0001485003) (Filer)
185dPR
Carisma Announces Delisting from Nasdaq and SEC Deregistration
PHILADELPHIA, Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to proceed with the voluntary delisting of its common stock from The Nasdaq Stock Market LLC ("Nasdaq") and the deregistration of its common stock in order to suspend and ultimately terminate the Company's reporting obligations under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"). As previously reported, as a result of the Company's previously disclosed noncomp

Analyst ratings

Last 8

Dec 12Robert W. Baird•Update
Neutral$1.00$10.00-
Dec 10BTIG Research•Update
Neutral--
Apr 11BTIG Research•Update
Buy$6.00-
Oct 3CapitalOne•Update
Overweight$10.00-
Jul 6Evercore ISI•Update
Outperform$12.00-
May 31Jefferies•Update
Buy$7.00$0.60-
May 24H.C. Wainwright•Update
Buy$10.00-
Apr 14Robert W. Baird•Update
Outperform$10.00-

Peers

Quick links

CARM FAQ

6 questions

Where does CARM stock trade?
Carisma Therapeutics Inc. (CARM) is listed on NASDAQ.
What sector and industry is CARM in?
Carisma Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
When did Carisma Therapeutics Inc. go public?
Carisma Therapeutics Inc. (CARM) completed its IPO in 2014.
What are analysts saying about CARM?
Carisma Therapeutics Inc. has had 8 recent analyst actions on file. The most recent action was from Robert W. Baird: Neutral with a $100.00 price target on 2024-12-12.
What companies are similar to CARM?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare CARM side-by-side with any of them on Quantisnow.
How can I track CARM on Quantisnow?
Quantisnow aggregates Carisma Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CARM to receive live email and push alerts on every new disclosure.